Logo image of ALX.AS

ALUMEXX N.V. (ALX.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:ALX - NL0012194724 - Common Stock

1.36 EUR
+0.02 (+1.49%)
Last: 12/4/2025, 7:00:00 PM
Fundamental Rating

2

Overall ALX gets a fundamental rating of 2 out of 10. We evaluated ALX against 26 industry peers in the Building Products industry. ALX may be in some trouble as it scores bad on both profitability and health. ALX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALX had negative earnings in the past year.
ALX had a positive operating cash flow in the past year.
In the past 5 years ALX has always been profitable.
Of the past 5 years ALX 4 years had a positive operating cash flow.
ALX.AS Yearly Net Income VS EBIT VS OCF VS FCFALX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M 4M

1.2 Ratios

With a Return On Assets value of -1.14%, ALX is not doing good in the industry: 80.77% of the companies in the same industry are doing better.
The Return On Equity of ALX (-8.83%) is worse than 84.62% of its industry peers.
ALX's Return On Invested Capital of 3.81% is on the low side compared to the rest of the industry. ALX is outperformed by 69.23% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALX is below the industry average of 10.18%.
Industry RankSector Rank
ROA -1.14%
ROE -8.83%
ROIC 3.81%
ROA(3y)2.13%
ROA(5y)5.78%
ROE(3y)8.97%
ROE(5y)14.04%
ROIC(3y)5.37%
ROIC(5y)9.3%
ALX.AS Yearly ROA, ROE, ROICALX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

ALX's Profit Margin has declined in the last couple of years.
The Operating Margin of ALX (3.22%) is worse than 76.92% of its industry peers.
ALX's Operating Margin has improved in the last couple of years.
ALX's Gross Margin of 50.98% is fine compared to the rest of the industry. ALX outperforms 76.92% of its industry peers.
In the last couple of years the Gross Margin of ALX has grown nicely.
Industry RankSector Rank
OM 3.22%
PM (TTM) N/A
GM 50.98%
OM growth 3Y1.89%
OM growth 5Y7.97%
PM growth 3Y-31.04%
PM growth 5Y-8.8%
GM growth 3Y26.81%
GM growth 5Y20.74%
ALX.AS Yearly Profit, Operating, Gross MarginsALX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

1

2. Health

2.1 Basic Checks

ALX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALX has about the same amount of shares outstanding.
Compared to 5 years ago, ALX has more shares outstanding
ALX has a better debt/assets ratio than last year.
ALX.AS Yearly Shares OutstandingALX.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
ALX.AS Yearly Total Debt VS Total AssetsALX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

ALX has an Altman-Z score of 0.71. This is a bad value and indicates that ALX is not financially healthy and even has some risk of bankruptcy.
ALX has a Altman-Z score of 0.71. This is amonst the worse of the industry: ALX underperforms 84.62% of its industry peers.
The Debt to FCF ratio of ALX is 8.71, which is on the high side as it means it would take ALX, 8.71 years of fcf income to pay off all of its debts.
ALX's Debt to FCF ratio of 8.71 is on the low side compared to the rest of the industry. ALX is outperformed by 69.23% of its industry peers.
ALX has a Debt/Equity ratio of 2.88. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.88, ALX is doing worse than 88.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.88
Debt/FCF 8.71
Altman-Z 0.71
ROIC/WACC0.66
WACC5.8%
ALX.AS Yearly LT Debt VS Equity VS FCFALX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

ALX has a Current Ratio of 0.94. This is a bad value and indicates that ALX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.94, ALX is doing worse than 80.77% of the companies in the same industry.
ALX has a Quick Ratio of 0.94. This is a bad value and indicates that ALX is not financially healthy enough and could expect problems in meeting its short term obligations.
ALX has a Quick ratio of 0.25. This is amonst the worse of the industry: ALX underperforms 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.25
ALX.AS Yearly Current Assets VS Current LiabilitesALX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

3

3. Growth

3.1 Past

ALX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -120.00%.
The Earnings Per Share has been growing by 48.17% on average over the past years. This is a very strong growth
ALX shows a decrease in Revenue. In the last year, the revenue decreased by -3.37%.
The Revenue has been growing by 76.03% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-120%
EPS 3Y9.7%
EPS 5Y48.17%
EPS Q2Q%-133.33%
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y80.47%
Revenue growth 5Y76.03%
Sales Q2Q%-0.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALX.AS Yearly Revenue VS EstimatesALX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2

4. Valuation

4.1 Price/Earnings Ratio

ALX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALX.AS Price Earnings VS Forward Price EarningsALX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

ALX's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, ALX is valued cheaper than 96.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.44
EV/EBITDA 8.7
ALX.AS Per share dataALX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALUMEXX N.V.

AMS:ALX (12/4/2025, 7:00:00 PM)

1.36

+0.02 (+1.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners68.55%
Ins Owner ChangeN/A
Market Cap9.86M
Revenue(TTM)39.09M
Net Income(TTM)-400.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF 3.44
P/OCF 3.04
P/B 2.47
P/tB N/A
EV/EBITDA 8.7
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.4
FCFY29.11%
OCF(TTM)0.45
OCFY32.86%
SpS5.39
BVpS0.55
TBVpS-1.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.14%
ROE -8.83%
ROCE 6.63%
ROIC 3.81%
ROICexc 3.81%
ROICexgc 14.36%
OM 3.22%
PM (TTM) N/A
GM 50.98%
FCFM 7.34%
ROA(3y)2.13%
ROA(5y)5.78%
ROE(3y)8.97%
ROE(5y)14.04%
ROIC(3y)5.37%
ROIC(5y)9.3%
ROICexc(3y)6.37%
ROICexc(5y)20.79%
ROICexgc(3y)22.05%
ROICexgc(5y)N/A
ROCE(3y)9.31%
ROCE(5y)16.14%
ROICexgc growth 3Y-36.12%
ROICexgc growth 5Y-30.83%
ROICexc growth 3Y-39.65%
ROICexc growth 5Y-14.2%
OM growth 3Y1.89%
OM growth 5Y7.97%
PM growth 3Y-31.04%
PM growth 5Y-8.8%
GM growth 3Y26.81%
GM growth 5Y20.74%
F-Score4
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 2.88
Debt/FCF 8.71
Debt/EBITDA 3.35
Cap/Depr 14.05%
Cap/Sales 0.95%
Interest Coverage 0.95
Cash Conversion 83.2%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.25
Altman-Z 0.71
F-Score4
WACC5.8%
ROIC/WACC0.66
Cap/Depr(3y)14.63%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.16%
Cap/Sales(5y)N/A
Profit Quality(3y)385.48%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-120%
EPS 3Y9.7%
EPS 5Y48.17%
EPS Q2Q%-133.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.37%
Revenue growth 3Y80.47%
Revenue growth 5Y76.03%
Sales Q2Q%-0.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-69.57%
EBIT growth 3Y83.88%
EBIT growth 5Y90.07%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y995.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y616.81%
OCF growth 3YN/A
OCF growth 5YN/A

ALUMEXX N.V. / ALX.AS FAQ

What is the ChartMill fundamental rating of ALUMEXX N.V. (ALX.AS) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALX.AS.


What is the valuation status of ALUMEXX N.V. (ALX.AS) stock?

ChartMill assigns a valuation rating of 2 / 10 to ALUMEXX N.V. (ALX.AS). This can be considered as Overvalued.


How profitable is ALUMEXX N.V. (ALX.AS) stock?

ALUMEXX N.V. (ALX.AS) has a profitability rating of 3 / 10.


Can you provide the financial health for ALX stock?

The financial health rating of ALUMEXX N.V. (ALX.AS) is 1 / 10.